AVANTAX ADVISORY SERVICES, INC. - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
AVANTAX ADVISORY SERVICES, INC. ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2022$4,000
-63.6%
22,0000.0%0.00%
Q2 2022$11,000
-15.4%
22,0000.0%0.00%
Q1 2022$13,000
-60.6%
22,000
-59.3%
0.00%
Q4 2021$33,000
+6.5%
54,000
+68.8%
0.00%
-100.0%
Q3 2021$31,000
-11.4%
32,0000.0%0.00%0.0%
Q2 2021$35,000
+288.9%
32,000
+88.2%
0.00%
Q2 2020$9,000
+50.0%
17,0000.0%0.00%
Q1 2020$6,000
-50.0%
17,0000.0%0.00%
Q4 2019$12,000
+71.4%
17,000
+70.0%
0.00%
Q3 2019$7,00010,0000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders